Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- ChecktodayChange DetectedThe revision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a platform update; visible study history and details remain unchanged.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History and the previous revision v3.5.3 was removed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s displayed application/revision indicator is updated from v3.5.2 to v3.5.3, reflecting a backend/UI version bump rather than a change to the clinical trial record.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision history now includes Revision: v3.5.2; Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the record history. This updates the page’s version log to reflect the latest changes.SummaryDifference0.1%

- Check86 days agoChange DetectedNew history entry added for Revision v3.4.3 with a Study Status update, and the previous Revision v3.4.2 entry (dated 2025-11-20) was removed.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.